Human Longevity: What the Research Actually Shows

Human longevity research studies how to extend healthspan, lifespan, or both. The strongest human evidence supports basics like not smoking, regular physical activity, sleep, nutrition, and managing cardiometabolic risk. Many drugs, peptides, and supplements are still investigational for longevity, so claims should be separated by evidence type: human clinical, observational, animal, or cell research.

What does “human longevity” actually mean?

Human longevity means studying how long people live, how well they function while alive, or both. A useful longevity plan should ask a simple question: does this help a person stay healthier, safer, and more functional over time?

Lifespan vs healthspan

Lifespan is the total length of life. Healthspan is the part of life spent in good function, with fewer years limited by disease, frailty, or disability. Many longevity researchers now focus on healthspan because it can be measured sooner than lifespan in human studies.

Aging biology vs disease prevention

Aging biology looks at processes such as cellular senescence, mitochondrial function, DNA damage, inflammation, and changes in gene regulation. Disease prevention focuses on known causes of illness, such as high blood pressure, diabetes, tobacco exposure, obesity, and cancer risk. Both matter, but the human evidence is much stronger for prevention and risk reduction than for any single “anti-aging” compound 1.

Why biomarkers are not the same as living longer

Biomarkers are measurements, such as blood sugar, cholesterol, inflammatory markers, or epigenetic clock readings. They can help researchers study biological aging, but a biomarker change does not prove longer life. Epigenetic clocks, first developed using DNA methylation patterns, can estimate biological age, but they are still research tools rather than proven lifespan outcomes 2.

What evidence is strongest for healthy aging in humans?

The strongest evidence for healthy aging comes from large human studies and public-health guidance. Physical activity is one of the clearest examples: adults are generally advised to aim for 150 to 300 minutes of moderate aerobic activity per week, plus muscle-strengthening activity at least 2 days per week 3.

Physical activity and muscle preservation

Human observational studies link regular physical activity with lower risk of early death. In a large pooled analysis, leisure-time physical activity was associated with longer life expectancy, even at activity levels below guideline targets 4. Exercise can still cause injury, low blood sugar in some people with diabetes, or heart symptoms in higher-risk adults, so people with heart disease, chest pain, fainting, or major medical conditions should ask a clinician how to start safely.

Cardiometabolic risk management

Cardiometabolic risk means risks tied to weight, blood pressure, cholesterol, blood sugar, liver fat, and heart health. Managing these risks is not glamorous, but it is one of the most evidence-based ways to support long-term health. In the SELECT trial, semaglutide 2.4 mg once weekly reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, compared with placebo; individual results vary, and the trial studied the active ingredient in an FDA-approved product, not compounded formulations 5. GLP-1 medicines can cause nausea, vomiting, diarrhea, constipation, gallbladder problems, and rare pancreatitis, and they are not appropriate for everyone 6.

Sleep, nutrition, alcohol, and tobacco

Sleep, diet quality, alcohol intake, and tobacco exposure affect long-term disease risk. The CDC states that cigarette smoking harms nearly every organ and is a leading preventable cause of disease and death in the United States 7. Cutting back on alcohol and improving diet can also lower cardiometabolic risk, but very restrictive diets, heavy supplement use, or sudden fasting plans may be unsafe for people with diabetes, eating-disorder history, pregnancy, kidney disease, or medication interactions.

Preventive care and screening

Preventive care is part of longevity medicine because it finds risk earlier. Blood pressure checks, lipid screening, diabetes screening, vaccines, cancer screening, and medication review are practical steps with real human evidence behind them. The U.S. Preventive Services Task Force recommends statin use for certain adults with cardiovascular risk factors and enough 10-year risk, showing how prevention decisions depend on personal risk rather than age alone 8.

What are scientists studying to slow biological aging?

Biological aging research looks at the cell-level changes that make tissues less resilient over time. Many ideas are promising, but most are not yet proven to improve human lifespan.

The “hallmarks of aging” framework groups major aging pathways, including genomic instability, telomere attrition, epigenetic change, mitochondrial dysfunction, senescence, and altered nutrient sensing 9. It is a useful map, not proof that any one intervention changes how long people live.

How should patients read longevity research claims?

A good longevity claim tells you what was studied, in whom, for how long, and what outcome changed. The evidence level matters as much as the headline.

This is why we avoid saying that a peptide, supplement, or biomarker plan “reverses aging.” A biomarker may move in a favorable direction, but the patient-centered questions are harder: fewer heart attacks, fewer fractures, better strength, better cognition, fewer hospitalizations, and longer healthy life.

Which medications and peptides are discussed in longevity research?

Several medicines and peptides are discussed in longevity medicine, but the evidence is mixed. NAD+, sermorelin, GHK-Cu, glutathione, low-dose naltrexone, semaglutide, and tirzepatide should be judged by human outcomes, safety, and monitoring needs—not by hype.

NAD+ and NAD+ precursors

NAD+ means nicotinamide adenine dinucleotide, a molecule cells use in energy metabolism and DNA-repair signaling. Human trials of NAD+ precursors have shown that blood NAD-related metabolites can rise, but they have not proven longer human lifespan. In one randomized trial, nicotinamide riboside increased NAD+ metabolites in older adults; the study was short and focused on safety and biomarkers, not lifespan 10. Reported issues can include flushing, nausea, headache, and changes in labs, and people with cancer history, liver disease, kidney disease, pregnancy, or complex medication lists should use clinician guidance.

Sermorelin and growth hormone pathways

Sermorelin is a growth hormone-releasing hormone analog that stimulates the body’s growth hormone pathway. Growth hormone pathways are tied to body composition, sleep, tissue repair, and metabolism, but more growth hormone is not automatically better for aging. Trials of growth hormone in healthy older adults have shown body-composition changes but also adverse effects such as edema, joint pain, carpal tunnel symptoms, and insulin resistance concerns 11. Sermorelin is discussed in longevity care, but it has not been proven to extend human lifespan.

GHK-Cu copper peptide

GHK-Cu is a copper peptide studied mostly in skin biology, wound signaling, and tissue remodeling. Much of the evidence is cell, animal, or cosmetic-skin research rather than human lifespan research. In human skin studies, copper-peptide-containing products have been studied for appearance and repair-related endpoints, not living longer 12. Possible issues include skin irritation, allergy, and sensitivity, especially with topical use.

Glutathione and oxidative stress

Glutathione is an antioxidant tripeptide made from three amino acids. It helps cells manage oxidative stress, but oxidative stress is only one part of aging biology. In a randomized controlled trial, oral glutathione increased body stores of glutathione in adults over 6 months; the study did not test lifespan or major clinical aging outcomes 13. Side effects can include gastrointestinal symptoms, rash, bronchospasm risk in sensitive people, and unknown risks in pregnancy or complex illness.

Low-dose naltrexone and inflammation

Low-dose naltrexone means naltrexone, an opioid receptor antagonist, used at lower doses off-label in some inflammatory and pain conditions. It is being discussed because immune signaling and inflammation are part of aging biology. Small human studies in conditions such as fibromyalgia suggest possible symptom effects, but this is not lifespan evidence 14. It can interact with opioid pain medicines and may cause sleep changes, vivid dreams, nausea, headache, or mood effects.

GLP-1 medications and cardiometabolic health

Ozempic, Wegovy, and Rybelsus are brand names for semaglutide, a GLP-1 receptor agonist; compounded semaglutide via state-licensed 503A pharmacy is a separate compounded formulation. Mounjaro and Zepbound are brand names for tirzepatide, a dual GIP/GLP-1 receptor agonist; compounded tirzepatide via state-licensed 503A pharmacy is also a separate compounded formulation. These medications are not proven “longevity drugs,” but cardiometabolic risk reduction is relevant to healthspan. FDA labeling describes risks including gastrointestinal side effects, gallbladder disease, pancreatitis warnings, and contraindications related to medullary thyroid carcinoma or MEN2 for these drug classes 6, 15.

Can longevity peptides extend human lifespan?

No longevity peptide has been proven to extend human lifespan. Some peptides and related compounds may support specific pathways or biomarkers, but that is different from proving people live longer.

What human evidence can and cannot show

Human trials can test safety, lab markers, symptoms, body composition, skin measures, or disease outcomes. They usually do not run long enough to prove lifespan extension. A short-term improvement in a lab value may be useful, but it should not be sold as proof of longevity.

Why animal or cell findings do not prove human lifespan benefit

Animal studies can test mechanisms faster because animals have shorter lifespans. Cell studies can show how a compound affects signaling pathways. Both are useful for discovery, but humans are more complex, with different biology, exposures, diseases, and medication use.

Safety, eligibility, and monitoring questions

Safety depends on the compound, dose, route, health history, and other medications. People with cancer, autoimmune disease, pregnancy, breastfeeding, kidney or liver disease, heart disease, diabetes, psychiatric illness, or hormone-sensitive conditions need extra caution. A licensed clinician should review goals, risks, labs when appropriate, and stop rules before any prescription treatment.

Longevity support at Chia: what clinician-reviewed options look like

At Chia, we offer online, clinician-reviewed longevity-support options for patients who may be appropriate candidates. Chia prescriptions require a licensed-provider review, and dosing is guided over time rather than chosen from a generic internet protocol.

Our Foundation Longevity protocol includes Sermorelin Injection, NAD+ Injection, and Glutathione Injection, with plans currently starting from $399/mo. Our Glow protocol includes GHK-Cu Cream, Glutathione Injection, and NAD+ Injection, with plans currently starting from $349/mo. These protocols are designed around healthspan-support goals and evidence limits, not promises of lifespan extension.

Chia also offers NAD+, Sermorelin, and Glutathione as individual treatments, along with GHK-Cu cream through the Glow protocol and GHK-Cu product page. Treatment begins with a short online health questionnaire, then a licensed US provider reviews your history and prescribes only where clinically appropriate. Patients can message the care team through the patient portal between visits.

For cardiometabolic goals, Chia offers compounded semaglutide injection and compounded tirzepatide tablets or injection, with microdosing plans available for both where clinically appropriate. These are compounded formulations, not FDA-approved brand drugs, and results from brand-drug trials should not be assumed for compounded products.

Who should be cautious with longevity treatments?

Anyone can be harmed by the wrong treatment, even if the goal is healthy aging. Safety screening matters more than trend-chasing.

• People with active cancer, recent cancer treatment, unexplained weight loss, or immune disease should talk with a licensed clinician before using peptides, hormones, or immune-active treatments.
• People who are pregnant, trying to conceive, or breastfeeding should avoid starting longevity medications or peptides unless a clinician specifically reviews the risks.
• People taking opioids should not start low-dose naltrexone without medical guidance because naltrexone can block opioid effects and may trigger withdrawal.
• People with diabetes, gallbladder disease, pancreatitis history, thyroid cancer risk, or severe gastrointestinal disease need careful review before GLP-1 or GIP/GLP-1 treatment.
• People with kidney disease, liver disease, heart disease, psychiatric illness, or many medications should ask about monitoring and stop rules before starting anything new.

How can someone choose a safe longevity program?

A safe longevity program should be clear about evidence, source, side effects, and follow-up. Avoid any program that promises lifespan extension or claims to reverse aging.

1. 1Look for clinician review before prescription treatment, not a checkout cart for injections or peptides.
2. 2Ask whether claims are based on human randomized trials, human observational data, animal studies, cell studies, or biomarkers.
3. 3Avoid guaranteed lifespan claims, before-and-after promises, and “no side effect” language.
4. 4Use treatments from licensed medical channels and state-licensed pharmacies, not no-prescription research-chemical vendors.
5. 5Tie goals to healthspan: strength, sleep quality, metabolic risk, pain, energy, function, and safe monitoring.

At Chia, our role is to help patients sort the useful from the overclaimed. Some people are eligible for prescription longevity-support treatment; others are better served by labs, preventive care, lifestyle work, or a different medical plan.

FAQ

Keep reading

Longevity

What Is Longevity Medicine? A Patient Guide to Healthspan, Testing, and Treatments

Longevity

What Is Longevity Health? A Patient Guide to Healthspan, Evidence, and Treatment Options

Peptides

What Are Peptides Used For? Medical Uses, Wellness Claims, and Safety